Início de Tratamento

The traditional relationship between the pharmaceutical industry and health professionals through face-to-face representatives has migrated to hybrid or even virtual models. And the relationship between doctors and patients has also changed with telemedicine, teleconsultation and digital prescription.

This new scenario generated a great challenge for the process of experimenting with new products for doctors and patients and also to guarantee the access of patients to the beginning of treatment to ensure the process of experimentation and adaptation.